(Q34977393)

5 August 2017

title

Phase II study of subcutaneous octreotide in adults with recurrent or progressive meningioma and meningeal hemangiopericytoma (English)

1 reference

5 August 2017

1 reference

Derek R Johnson

1

1 reference

5 August 2017

David W Kimmel

2

1 reference

5 August 2017

Patrick A Burch

3

1 reference

5 August 2017

Terrence L Cascino

4

1 reference

5 August 2017

Caterina Giannini

5

1 reference

5 August 2017

Wenting Wu

6

1 reference

5 August 2017

Jan C Buckner

7

1 reference

5 August 2017

publication date

1 May 2011

1 reference

5 August 2017

1 reference

5 August 2017

volume

13

1 reference

5 August 2017

issue

5

1 reference

5 August 2017

page(s)

530-535

1 reference

Phase II trials of erlotinib or gefitinib in patients with recurrent meningioma.

5 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Antitumor effects of somatostatin

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Salvage chemotherapy with CPT-11 for recurrent meningioma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Epidemiology of intracranial meningioma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Temozolomide for treatment-resistant recurrent meningioma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Intracranial meningeal hemangiopericytoma: the role of radiotherapy: report of 29 cases and review of the literature

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Management of recurrent meningeal hemangiopericytoma

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Hydroxyurea for treatment of unresectable and recurrent meningiomas. II. Decrease in the size of meningiomas in patients treated with hydroxyurea

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Treatment of meningioma with octreotide

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Radiation therapy of meningiomas

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial

8 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Interferon-alpha for recurrent World Health Organization grade 1 intracranial meningiomas

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Stereotactic radiation treatment for recurrent nonbenign meningiomas.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Expression of somatostatin receptor mRNA in human meningiomas and their implication in in vitro antiproliferative activity.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Clinical relevance of 111In-octreotide scans in CNS tumors.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Somatostatin receptor scintigraphy in the differential diagnosis of meningioma.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Somatostatin receptor scintigraphy in brain tumors and pituitary tumors: first experiences.

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

High incidence of somatostatin receptors in human meningiomas: biochemical characterization

26 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3093340

Somatostatin suppression of meningioma cell proliferation in vitro

26 October 2018

1 reference

12 December 2020

Successful treatment of meningioma with octreotide

1 reference

12 December 2020

Octreotide treatment of acromegaly. A randomized, multicenter study

1 reference

12 December 2020

Gastroenteropancreatic endocrine tumours: effect of Sandostatin on tumour growth. The German Sandostatin Study Group

1 reference

12 December 2020

Clinical use of octreotide in unresectable meningiomas. A report of three cases

1 reference

12 December 2020

Gamma knife surgery for atypical meningiomas

1 reference

12 December 2020

Recurrent meningioma: salvage therapy with long-acting somatostatin analogue

1 reference

12 December 2020

Sstr2A immunohistochemical expression in human meningiomas: is there a correlation with the histological grade, proliferation or microvessel density?

1 reference

12 December 2020

Hemangiopericytoma of the meninges. Mayo Clinic experience

1 reference

12 December 2020

Identifiers

DOI

10.1093/NEUONC/NOR044

1 reference

5 August 2017

1 reference

5 August 2017

1 reference